Albata Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 23 Year, 8 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth 60.45%
- Profit Growth 4.05%
- Ebitda -17111.44%
- Net Worth 26.16%
- Total Assets 167.89%
About Albata Biotech
Albata Biotech Pvt. Ltd. (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 May 2001 and has a history of 23 years and eight months. Its registered office is in Delhi, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gurprit Sodhi and Bhupendra Singh serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24219DL2001PTC110912
-
Company No.
110912
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 May 2001
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Albata Biotech Pvt. Ltd. offer?
Albata Biotech Pvt. Ltd. offers a wide range of products and services, including Insecticides, Organic Pesticides, Fertilizers and Soil Additives, Organic Fertilizers and Manure, Bio Insecticides, Bio Larvicide, Bio Miticide, Fertilizer, Plant Growth Promoters, Insecticides and Pesticides.
Who are the key members and board of directors at Albata Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gurprit Sodhi
|
Director | 27-Oct-2014 | Current |
|
Bhupendra Singh
|
Director | 16-Feb-2021 | Current |
Financial Performance of Albata Biotech.
Albata Biotech Pvt. Ltd., for the financial year ended 2020, experienced significant growth in revenue, with a 60.45% increase. The company also saw a slight improvement in profitability, with a 4.05% increase in profit. The company's net worth Soared by an impressive increase of 26.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Albata Biotech?
In 2019, Albata Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Albata Biotech?
Unlock and access historical data on people associated with Albata Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Albata Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Albata Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
